Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Report of 5 Cases of Extramedullary Myeloma with Central Nervous System Involvement Treated with a Combination of Carfilzomib/Thalidomide/Dexamethasone As a First Line Treatment at a Single Institution in Mexico

Ramiro Espinoza, MD, Diana Berenice Nolasco, MD, Sosa Alejandro, MD, Zapata Nidia, MD, Cervera Eduardo, MD, Myrna Candelaria, MD PhD, Alarcon Silvia, MD, Espinoza Vicente, MD, Vieyra Magnolia, MD, Gutierrez Jorge, MD, Luis Sosa, MD, Escobedo Maria, LPN, Gonzalez Reynaldo, CHEM, Oñate Luis, MD PhD, Lahuerta Juan, MD, Labardini Juan, MD

Blood (2016) 128 (22): 5704.

https://doi.org/10.1182/blood.V128.22.5704.5704

Published: 2016

Journal Articles

Phase II Study of Epigenetic Therapy with Hydralazine and Valproate in Cutaneous T-Cell Lymphoma

Ramiro Espinoza, MD, Manuel Aguilar Rodríguez, MD, Nidia P. Zapata, MD, Jorge Carlos Torres, Sr., Resident, Diana Berenice Nolasco, MD, Silvia Eugenia Alarcon Barrios, Eduardo Cervera, Myrna Candelaria, MD PhD, Valentin Lozano, Alejandro Sosa, Javier Espinoza, Magnolia Vieyra, Jorge Gutierrez, Luis Mario Sosa, Reynaldo González, Luis Oñate, Juan Labardini

Blood (2016) 128 (22): 5362.

https://doi.org/10.1182/blood.V128.22.5362.5362

Published: 2016

Journal Articles

Local Experience with Autologous Stem Cell Transplant in Multiple Myeloma at a Public Institution (Instituto Nacional de Cancerologia)

Eduardo Cervera, Jorge Carlos Torres, Sr., Nidia P. Zapata, MD, Juan Rafael Labardini, Sr., Hematologist, Jose Ramiro Espinoza, Hematologist, Magnolia Vieyra, MD, Antonio Sosa, Valentin Lozano, MD, Myrna Candelaria, MD PhD, Abelardo Meneses, MD

Blood (2015) 126 (23): 5504.

https://doi.org/10.1182/blood.V126.23.5504.5504

Published: 2015

Journal Articles

Impact Of a Federal Program On response Rate & Survival, In a Cohort Of Patients With Diffuse Large B- Cell Lymphoma. Analysis In a Single National Reference Institution In Mexico

Myrna Candelaria, MD, PhD, Juan Labardini, MD, PhD, Ana Florencia Ramirez, Alejandro Aviles, MD, Enrique Estrada-Lobato, MD, Abelardo Meneses-Garcia, Md, PhD, Alejandro Mohar, MD, PhD

Blood (2013) 122 (21): 5608.

https://doi.org/10.1182/blood.V122.21.5608.5608

Published: 2013

Journal Articles

Chronic Myeloid Leukemia Philadelphia Chromosome Positive (CML Ph+) with Imatinib (IM) Intolerance or Resistant Disease. Response to Thalidomide (TALI) Treatment. Preliminary Report of a Serial of Cases with Encouraging Results

Rafael Hurtado, MD, Jose Pablo Vargas Viveros, MD, Carrillo Muñoz Silvia, RN, Judith Cruz-Velazquez, Myrna Candelaria, MD, PhD, Eduardo Cervera, MD

Blood (2012) 120 (21): 1689.

https://doi.org/10.1182/blood.V120.21.1689.1689

Published: 2012

NARROW

Report of 5 Cases of Extramedullary Myeloma with Central Nervous System Involvement Treated with a Combination of Carfilzomib/Thalidomide/Dexamethasone As a First Line Treatment at a Single Institution in Mexico

Phase II Study of Epigenetic Therapy with Hydralazine and Valproate in Cutaneous T-Cell Lymphoma

Local Experience with Autologous Stem Cell Transplant in Multiple Myeloma at a Public Institution (Instituto Nacional de Cancerologia)

Impact Of a Federal Program On response Rate & Survival, In a Cohort Of Patients With Diffuse Large B- Cell Lymphoma. Analysis In a Single National Reference Institution In Mexico

Chronic Myeloid Leukemia Philadelphia Chromosome Positive (CML Ph+) with Imatinib (IM) Intolerance or Resistant Disease. Response to Thalidomide (TALI) Treatment. Preliminary Report of a Serial of Cases with Encouraging Results

Email alerts

ASH Publications

American Society of Hematology

Report of 5 Cases of Extramedullary Myeloma with Central Nervous System Involvement Treated with a Combination of Carfilzomib/Thalidomide/Dexamethasone As a First Line Treatment at a Single Institution in Mexico

Phase II Study of Epigenetic Therapy with Hydralazine and Valproate in Cutaneous T-Cell Lymphoma

Local Experience with Autologous Stem Cell Transplant in Multiple Myeloma at a Public Institution (Instituto Nacional de Cancerologia)

Impact Of a Federal Program On response Rate & Survival, In a Cohort Of Patients With Diffuse Large B- Cell Lymphoma. Analysis In a Single National Reference Institution In Mexico

Chronic Myeloid Leukemia Philadelphia Chromosome Positive (CML Ph+) with Imatinib (IM) Intolerance or Resistant Disease. Response to Thalidomide (TALI) Treatment. Preliminary Report of a Serial of Cases with Encouraging Results

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only